SCHEMBL26597068

SCHEMBL26597068

CC(C)(C)n1c2ccccc2c2ccc(N)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.47
▸ KMT2A Q03164 6/20 0.47
▸ ALDH1A1 P00352 5/20 0.47
▸ MAPT P10636 5/20 0.47
▸ HPGD P15428 5/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HBB P68871 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CCND1 P24385 1/20 0.38
▸ GPR3 P46089 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HTR6 P50406 3/20 0.37
▸ KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17827625 0.83 GPR3 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL2608424 0.82 GPR3 (0.52) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL29625463 0.82 GPR3 (0.52) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17827622 0.81 GPR3 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18381750 0.80 GPR3 (0.50) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25648118 0.80 KIF11 (0.39) KMT2AMAPTKDM4EHTTTDP1
SCHEMBL24617586 0.79 KIF11 (0.47) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24617791 0.78 HPGD (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL16230951 0.78 MAOA (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL15745984 0.77 KDM4E (0.47) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof Lakewood Amedex, Inc. (US) 2023-10-24 — — US disclosed
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof Lakewood Amedex, Inc. (US) 2023-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof CAT, MPO, NISCH MEN1 2920/4885KMT2A 4874/4885ALDH1A1 2110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback